Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 23, 2016
Insider Transaction Report
Form 4
Greve Jeffrey W.
Vice President, Controller
Transactions
- Award
Stock Option to Buy
2016-02-22+10,507→ 10,507 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (10,507 underlying) - Award
Common Stock
2016-02-22+4,962→ 4,962 total
Footnotes (1)
- [F1]The option vests in four equal installments beginning on February 22, 2017.